About
All Posts
Partner
Logo
Login
Subscribe
Logo
  • Home
  • Posts
  • OpenAI reverses course, keeps nonprofit in charge of for-profit entity

May 6, 2025

OpenAI reverses course, keeps nonprofit in charge of for-profit entity

Bay Area Times
Bay Area Times
OpenAI reverses course, keeps nonprofit in charge of for-profit entity

Brought to you by:

Top stories today:

  1. OpenAI reverses course, keeps nonprofit in charge of for-profit entity
  2. Apple appeals ruling in Epic Games’ case after lower court setback
  3. Trump raising millions from Mon.’s $1.5M-per-head crypto dinner
  4. OpenAI said to reach deal to buy Windsurf for $3B
  5. UNITY Bio lays off entire workforce, seeks ā€œstrategic alternativesā€

Follow us on X | Instagram | Advertise

0. Data and calendar

All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).

All times are ET.

Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):

1. OpenAI reverses course, keeps nonprofit in charge of for-profit entity

  • The nonprofit will keep control and a major stake as the business arm becomes a public benefit corporation (PBC).

  • Dec. 2024: OpenAI announced the PBC would ā€œrun and controlā€ its operations and business over time.

  • The nonprofit ā€œwill hireā€ a team ā€œto pursue charitable initiatives,ā€ the company had said.

  • Elon Musk and Encode were among many who opposed the earlier plan.

  • Microsoft is reportedly the biggest holdout in the new restructuring plan.

  • ā€œWe continue to work closely with Microsoft,ā€ OpenAI said.

2. The protein that might stop arthritis is raising money. Seriously.*

Cytonics

Over 365 million people worldwide suffer from osteoarthritis and there's still no cure, just painkillers and ice packs.

Cytonics’ CYT-108 is a lab-tweaked version of a natural protein (A2M) that blocks the enzymes that eat away at cartilage.

Backed by NIH grants and over 6,000 shareholders, Cytonics is now letting the public invest in its next clinical trial phase.

It’s a shot at finally treating the root cause of joint pain, not just managing it.

Invest in Cytonics and help take down arthritis at the molecular level

*Sponsored by Cytonics ($50,000 contracted). Prospective investors should review the offering materials for details, including all risk factors, before making an investment decision. Any investment involves significant risks, including the potential loss of the total investment. This advertisement is not an offer to sell or a solicitation of an offer to buy securities. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please read the offering circular before investing in Cytonics.

3. Apple appeals ruling in Epic Games’ case after lower court setback

Representational image generated using OpenAI’s ChatGPT.

  • Mon.: Apple filed a notice of appeal to the Ninth Circuit to challenge last week’s ruling.

  • The ruling blocks Apple from charging fees on purchases outside the App Store.

  • Apple was also referred to the federal prosecutor for a possible criminal probe.

4. Trump raising millions from Mon.’s $1.5M-per-head crypto dinner, $TRUMP token event

NYTimes.

Subscribe to keep reading

This content is free, but you must be subscribed to Bay Area Times to continue reading.

Already a subscriber?Sign in.Not now

Keep reading

Jul 30, 2026

Microsoft Cloud drives Q4 FY26 revenue +18% YoY to $90B, operating income +18%

Microsoft Cloud drives Q4 FY26 revenue +18% YoY to $90B, operating income +18%

Jul 29, 2026

OpenAI models breached Modal customer before Hugging Face

OpenAI models breached Modal customer before Hugging Face

Jul 28, 2026

Anthropic’s Amodei rejects open AI model ban, calls for testing

Anthropic’s Amodei rejects open AI model ban, calls for testing

Jul 27, 2026

Claude Opus 5 debuts, nears Fable 5 performance at 50% lower price

Claude Opus 5 debuts, nears Fable 5 performance at 50% lower price

Subscribe

Your morning briefing, free forever.

Get the latest news, resources, and more delivered straight to your inbox everyday.

The visual daily newsletter on business and tech. Analyzing the news with 1 visual per story. Join our 250,000+ subscribers here.

Copyright Ā© 2026 Bay Area Times.

BAT

Company

Legal

Privacy Policy

Terms of Service